| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 9e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |